Minerva brings in $6M equity round to treat uterine bleeding

Minerva Surgical, developer of medical devices used to treat irregular uterine bleeding, has brought in $6 million in equity, according to a filing with the SEC. Based in Cupertino, Calif., the company has been making and marketing medical devices targeted at women for more than 30 years.